Boothbay Fund Management LLC Raises Stock Position in Amdocs Limited $DOX

Boothbay Fund Management LLC grew its position in shares of Amdocs Limited (NASDAQ:DOX) by 4.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 189,840 shares of the technology company’s stock after purchasing an additional 8,431 shares during the period. Amdocs makes up 0.3% of Boothbay Fund Management LLC’s portfolio, making the stock its 25th biggest holding. Boothbay Fund Management LLC’s holdings in Amdocs were worth $17,321,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Quarry LP increased its holdings in shares of Amdocs by 42.2% in the 1st quarter. Quarry LP now owns 391 shares of the technology company’s stock worth $36,000 after buying an additional 116 shares during the last quarter. Rossby Financial LCC bought a new position in shares of Amdocs during the second quarter valued at about $41,000. SVB Wealth LLC purchased a new position in Amdocs in the 1st quarter worth approximately $43,000. Caitong International Asset Management Co. Ltd raised its holdings in Amdocs by 537.8% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 472 shares of the technology company’s stock valued at $43,000 after buying an additional 398 shares during the last quarter. Finally, Neo Ivy Capital Management bought a new position in shares of Amdocs during the second quarter valued at about $54,000. 92.02% of the stock is currently owned by institutional investors.

Amdocs Stock Up 0.7%

DOX opened at $79.35 on Friday. The firm’s 50 day simple moving average is $80.21 and its two-hundred day simple moving average is $85.31. The company has a market capitalization of $8.96 billion, a PE ratio of 15.71, a PEG ratio of 1.32 and a beta of 0.43. Amdocs Limited has a 1-year low of $74.32 and a 1-year high of $95.41. The company has a current ratio of 1.17, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.82 by $0.01. The firm had revenue of $1.15 billion during the quarter, compared to the consensus estimate of $1.15 billion. Amdocs had a net margin of 12.46% and a return on equity of 19.78%. The company’s revenue for the quarter was down 9.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.70 EPS. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS and its Q1 2026 guidance at 1.730-1.790 EPS. As a group, equities analysts forecast that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be given a $0.527 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a yield of 2.7%. Amdocs’s dividend payout ratio is presently 41.78%.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on DOX. Wolfe Research reaffirmed a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Weiss Ratings reissued a “hold (c)” rating on shares of Amdocs in a research report on Thursday, October 30th. Wall Street Zen downgraded shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Stifel Nicolaus cut their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Finally, Bank of America reduced their price target on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Two research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $97.00.

About Amdocs

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.